Cancer Immunotherapy Stocks List

Recent Signals

Date Stock Signal Type
2019-09-18 ARGSQ 20 DMA Support Bullish
2019-09-18 ARGSQ Stochastic Reached Overbought Strength
2019-09-18 GTBP 180 Bearish Setup Bearish Swing Setup
2019-09-18 GTBP 20 DMA Resistance Bearish
2019-09-18 GTBP Bollinger Band Squeeze Range Contraction
2019-09-18 HGEN Narrow Range Bar Range Contraction
2019-09-18 IMUC 20 DMA Support Bullish
2019-09-18 NWBO Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-09-18 NWBO 1,2,3 Pullback Bullish Bullish Swing Setup
2019-09-18 NWBO NR7 Range Contraction
2019-09-18 NWBO Narrow Range Bar Range Contraction
2019-09-18 VXLLF Bollinger Band Squeeze Range Contraction
2019-09-18 VXLLF Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-09-18 VXLLF 50 DMA Support Bullish

Cancer immunotherapy (sometimes called immuno-oncology) is the artificial stimulation of the immune system to treat cancer, improving on the system's natural ability to fight cancer. It is an application of the fundamental research of cancer immunology and a growing subspecialty of oncology. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules (e.g. carbohydrates). Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill.

More about Cancer Immunotherapy